Q1 2026 Holdings
Filed 2026-05-14 | 13 holdings | $599.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $153.2M | 3,220,627 | 25.6% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $132.3M | 18,245,691 | 22.1% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $79.1M | 889,824 | 13.2% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $76.6M | 8,550,954 | 12.8% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $44.4M | 1,333,333 | 7.4% |
| Lyell Immunopharma Inc(LYEL) | COM NEW | 55083R203 | $30.3M | 1,512,659 | 5.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $22.4M | 340,434 | 3.7% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $21.5M | 9,190,606 | 3.6% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $13.7M | 1,785,714 | 2.3% |
| Cvrx Inc(CVRX) | COM | 126638105 | $9.5M | 1,007,583 | 1.6% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $7.1M | 1,529,561 | 1.2% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $6.6M | 3,150,732 | 1.1% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $2.3M | 271,456 | 0.4% |